20311 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil Proline; Derivatives thereof, e.g. captopril
Systems and Methods to Treat Pain Locally
#902Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases
#903Methods for reducing levels of disease associated proteins
#904Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
#905Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
#906Amino acid derivatives
#907Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
#908Crystalline forms of [R-(R*.R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
#909Secondary binding site of dipeptidyl peptidase IV (DP IV)
#910Compositions and methods for reducing cardiovascular morbidity and/or mortality
#911Bone growth compositions and methods
#912Compounds promoting delivery of genes
#913Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
#914Use of inhibitors of the renin-angiotensin system
#915Fortifier
#916Methods and compositions for specific inhibition of protein splicing by small molecules
#917Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof
#918Omega-3 fatty acids and dyslipidemic agent for lipid therapy
#919Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1
#920Article with skin protecting and moisturizing compound
#921Combination therapy for endothelial dysfunction, angina and diabetes
#922Methods and agents for regulating angiotensin activity
#923Dual controlled release dosage form
#924Methods of cardioprotection using dichloroacetate in combination with an inotrope
#925Developmental animal model of temporal lobe epilepsy
#926Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
#927Developmental animal model of temporal lobe epilepsy
#928Preventing atrial fibrillation (af) with the use of stain drugs
#929Small molecules for the treatment of atherosclerosis
#930Therapeutic agent for diabetes mellitus
#9312-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation
#932Aza-peptide epoxides
#933Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease
#934Ace-inhibitors having antioxidant and no-donor activity
#935Amino acid composition
#936Tablet containing water-absorbing amino acid
#937Stabilized individually coated ramipril particles, compositions and methods
#938Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
#939Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#940Acylated 4-amidino- and -4-guanidinobenzylamines for inhibition of plasma kallikrein
#941Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
#942Stabilized ramipril compositions and methods of making
#943Method of using adapalene in acne maintenance therapy
#944Amino acid composition for improving central functions
#945Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
#946Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration
#947Combination of an dpp-iv inhibitor and a ppar-alpha compound
#948Methods and compositions for treating diseases associated with excesses in ACE
#949Inhalable formulations for treating pulmonary hypertension and methods of using same
#950Ophthalmic and ophthalmological use of a complex nutritive base in aqueous medium
#951Methods of treating alzheimer's disease using aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides
#952Amino acid composition and supplementary liquid containing the same
#953Method of prevention and treatment of atherosclerosis, peripheral vascular disease, coronary artery disease, and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
#954Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition
#955Reducing axon degeneration with proteasome inhibitors
#956Reducing ER stress in the treatment of obesity and diabetes
#957Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
#958Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
#959Systemic administration of therapeutic amino acids and N-acetylamino acids
#960Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation
#961Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker
#962Pharmaceutical combination
#963Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
#964Preventive or remedy for bedsore
#965Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
#966PERORAL PREPARATION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATATIS
#967Methods for decreasing beta amyloid protein
#968Formulations for non-parenteral use including hydrophobic cyclodextrins
#969Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
#970Oculoselective drugs and prodrugs
#971Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
#972Combination therapies utilizing benzamide inhibitors of the P2X7 receptor
#973Lipid-amino acid conjugates and methods of use
#974Methods for modulating phototoxicity
#975Pharmaceutical compositions with synchronized solubilizer release
#976Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
#977Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
#978Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
#979Novel methods of treatment for Fontan patients with protein losing enteropathy
#980Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
#981Nordihydroguaiartic derivatives for use in treatment of tumors
#982Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses
#983Treatment of diseases using ICE inhibitors
#984Cosmetic compositions and methods
#985Therapeutic combination
#986Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders
#987Combined use of a GLP-1 compound and another drug for treating dyslipidemia
#988Mycophenolate mofetil in diabetic nephropathy
#989Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease
#990Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
#991Compositions for improving mental performance
#992Pharmaceutical compositions containing keto-acids for endoperitoneal administration
#993Statins for the treatment of ocular hypertension and glaucoma
#994Methods of enhancing stem cell engraftment
#995ACE inhibitor-vasopressin antagonist combinations
#996Methods for enhancing the transport of glucose for balancing blood sugar levels
#997Protease activity of thrombin inhibits angiogenesis
#998Methods for enhancing the transport of glucose into muscle
#999Statin therapy for enhancing cognitive maintenance
#1000Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids
#1001Methods for restoring cognitive function following systemic stress
#1002Method of treating amyloid beta precursor disorders
#1003Method of treating amyloid beta precursor disorders
#1004Treating vascular events with statins by inhibiting PAR-1 and PAR-4
#1005Methods of controlling proliferation and differentiation of stem and progenitor cells
#1006Cancer therapy
#1007Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
#1008Mast cell-derived renin
#1009Methods and compositions for treating diseases associated with excesses in ACE
#1010Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders
#1011Stable pharmaceutical compositions comprising ace inhibitor(s)
#1012Simvastatin formulations and methods of making same
#1013Use of inhibitors of the renin-angiotensin system
#1014Use of inhibitors of the renin-angiotensin system
#1015Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
#1016Medicinal composition for lowering blood lipid level
#1017Medicinal composition for mitigating blood lipid or lowering blood homocysteine
#1018Medicinal composition containing an HMG-CoA reductase inhibitor
#1019Pharmaceutical compositions of quinapril
#1020Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
#1021Secondary binding site of dipeptidyl peptidase IV (DPIV)
#1022Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases
#1023Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD
#1024Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
#1025Combinations useful for the treatment of neuronal disorders
#1026Methods for the treatment of cancer
#1027Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#1028Statin-carboxyalkylether combinations
#1029Hemodialysis solutions and uses thereof
#1030Use of Vitamin Ds to treat kidney disease
#1031Treatment of female fertility conditions through modulation of the autonomic nervous system
#1032Use of ACE inhibitors for treatment of patients suffering from behavioral disorders
#1033Selective inhibition of cyclooxygenase 1 in the treatment of diabetic nephropathy
#1034Combinations useful for the treatment of neuronal disorders
#1035Sodium channel modulators
#1036Use of vitamin Ds to treat kidney disease
#1037Methods for treating conditions associated with the accumulation of excess extracellular matrix
#1038Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases
#1039Synergistic effect of amlodipine and atorvastatin on aortic endothelial cell nitric oxide release
#1040Method for the improvement of neuronal regeneration
#1041Methods of controlling proliferation and differentiation of stem and progenitor cells
#1042Methods and agents for regulating angiotensin activity
#1043Drug combination therapy
#1044Pharmaceutical compositions of amlodipine and atorvastatin
#1045Use of dipeptidyl peptidase IV effectors for normalizing the blood glucose level in mammals
#1046Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#1047Lisinopril/lercanidipine combination therapy
#1048Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases
#1049HDL-boosting combination therapy complexes
#1050Prenylation inhibitors reduce host cell permissiveness to viral replication
#1051Parmaceutical
#1052Enteral formulation
#1053Methods for treating autoimmune disorders, and reagents related thereto
#1054Method of reducing the risk of oxidative stress
#1055Potentiators of insulin secretion
#1056Heterocyclic thioester and ketone hair growth compositions and uses
#1057Multi-system therapy for diabetes, the metabolic syndrome and obesity
#1058Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase
#1059Pharmaceutical composition and method for retardation of the progression of atherosclerosis
#1060Composition and method for facilitating bone healing
#1061Protease inhibitor compositions for prevention and treatment of skin conditions
#1062Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
#1063Method for modulating phototoxicity
#1064Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
#1065Methods for treating conditions associated with the accumulation of excess extracellular matrix
#1066Process for forming amorphous atorvastatin
#1067Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
#1068Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
#1069Spray drying processes for forming solid amorphous dispersions of drugs and polymers
#1070Allylamides useful in the treatment of alzheimer's disease
#1071Treatment and prevention of cardiovascular events
#1072Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
#1073Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an HMG CoA reductase inhibitor
#1074Statin-MMP inhibitor combinations
#1075Nutritional composition and method of inhibiting smooth muscle cell contraction thereof
#1076Antibacterial agents
#1077Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release
#1078Use of growth hormone secretagogues for treatment of fibromyalgia
#1079Use of organic compounds
#1080Stable, highly pure L-cysteine compositions for injection and methods of use
#1081Stable, highly pure L-cysteine compositions for injection and methods of use
#1082Systems and methods for preparing and administering a hydrating supplement composition
#1083Amino acid compositions
#1084Stable, highly pure L-cysteine compositions for injection and methods of use
#1085Stable, highly pure L-cysteine compositions for injection and methods of use
#1086Stable, highly pure L-cysteine compositions for injection and methods of use
#1087Biologic enhancement formulation
#1088Stable, highly pure L-cysteine compositions for injection and methods of use
#1089Composition and method of treating conditions associated with extracellular matrix dysfunction by administering micronutrient composition
#1090Stable, highly pure L-cysteine compositions for injection and methods of use
#1091Stable, highly pure L-cysteine compositions for injection and methods of use
#1092Stable, highly pure L-cysteine compositions for injection and methods of use
#1093Stable, highly pure l-cysteine compositions for injection and methods of use
#1094Stable, highly pure L-cysteine compositions for injection and methods of use
#1095Amino acid compositions
#1096Amino acid compositions
#1097Biologic enhancement formulation
#1098Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
#1099Stable, highly pure L-cysteine compositions for injection and methods of use
#1100Stable, highly pure L-cysteine compositions for injection and methods of use
#1101Stable, highly pure L-cysteine compositions for injection and methods of use
#1102Methods, compositions and devices for treating cancer with illudofulvenes
#1103Stable, highly pure L-cysteine compositions for injection and methods of use
#1104Stable, highly pure L-cysteine compositions for injection and methods of use
#1105Enalapril formulations
#1106Method of safely administering nitrate dietary supplements and compositions
#1107Amino acid compositions